Research highlights potential Alzheimer's disease biomarker, finds biomarkers unaffected by cognitive, physical activity
Autolysosomnal proteins may be a significant Alzheimer's disease biomarker, as study findings in Neurology show patients with the disease exhibited higher levels of the proteins than healthy controls. Researchers compared blood exosomes obtained from patients with Alzheimer's disease (n=46) or frontotemporal dementia (n=16) when cognitively normal and one to 10 years later when diagnosed with case controls.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063